Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Lactoferrin + vitamin e + zinc** is an orally administered combination dietary supplement and over-the-counter drug primarily developed and marketed for the treatment of mild to moderate acne vulgaris. Lactoferrin is an iron-binding milk-derived protein with demonstrated antibacterial and anti-inflammatory effects. Vitamin E acts as an antioxidant, protecting skin cells from free radical damage and supporting overall skin health. Zinc is an essential mineral with anti-inflammatory and immune-modulatory effects, also known to regulate sebum production. Clinical trials have shown that this combination significantly reduces inflammatory and non-inflammatory acne lesions and improves skin quality and sebum control, with a strong safety profile and no significant adverse events reported. The drug is primarily developed and marketed in the Philippines under the brand name Lactezin[1][2][3][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactoferrin + vitamin e + zinc.